Side Effects of Guanfacine in Healthy Children
The most common side effects of guanfacine in healthy children are somnolence (drowsiness), dry mouth, fatigue, headache, and dizziness, with somnolence being the most frequently reported adverse effect affecting up to 38.6% of children. 1, 2
Common Side Effects
Guanfacine, an alpha-2A adrenergic receptor agonist, is FDA-approved for the treatment of ADHD in children and adolescents. Based on clinical evidence, the most frequently reported adverse effects include:
Sedation-related effects:
- Somnolence (38.6%)
- Fatigue (15.2%)
- Sedation (13.2%)
Other common side effects:
- Dry mouth (up to 54% dose-dependent)
- Headache (20.5%)
- Dizziness (up to 15% dose-dependent)
- Constipation (up to 15% dose-dependent)
- Upper abdominal pain (11.8%)
Cardiovascular Effects
Guanfacine can cause modest cardiovascular effects that are generally not clinically significant in healthy children:
- Mild decrease in blood pressure
- Mild decrease in heart rate (bradycardia)
These effects are typically less pronounced than with clonidine, which is another alpha-2 adrenergic agonist sometimes used for ADHD 4.
Timing and Duration of Side Effects
Side effects of guanfacine tend to follow a specific pattern:
- Most adverse effects occur during the initial dose titration period
- Many side effects (63.5%) resolve prior to discontinuation of the medication
- Adverse reaction reports tend to decrease over time with continued use 1, 3
Dose-Related Effects
The frequency of side effects shows a clear dose relationship:
- Higher doses (2-3 mg) are associated with significantly more adverse effects than lower doses (0.5-1 mg)
- At 3 mg dosing, dry mouth can affect up to 54% of patients and somnolence up to 39% 1
Discontinuation Considerations
In clinical trials, the dropout rate due to adverse effects ranged from 2% at 0.5 mg to 32% at 3 mg dosing 1. The most common reasons for discontinuation were:
- Somnolence
- Dry mouth
- Dizziness
- Fatigue
- Weakness
- Constipation
Extended-Release vs. Immediate-Release Formulation
The extended-release formulation of guanfacine (GXR) has some advantages over the immediate-release form:
- More effective for long-term management of ADHD
- Associated with fewer adverse effects
- Once-daily dosing improves adherence 5
Rare but Important Side Effects
Less common but noteworthy adverse effects include:
- Skin rash with exfoliation (rare)
- Mood changes/irritability (22.7% when combined with stimulants)
- Insomnia (4-5%)
- Hypotension (particularly orthostatic)
Comparison to Other ADHD Medications
Guanfacine has a different side effect profile compared to stimulant medications:
- Less potential for appetite suppression and growth effects
- No risk of abuse potential
- More sedation than stimulants
- Less sedation than clonidine (another alpha-2 agonist) 7, 4
Monitoring Recommendations
For children taking guanfacine, monitoring should include:
- Regular assessment of sedation and alertness
- Blood pressure and heart rate monitoring, especially during dose initiation
- Monitoring for signs of hypotension or dizziness
- Assessment of mood changes or irritability
Important Cautions
- Abrupt discontinuation should be avoided; the medication should be tapered gradually to prevent rebound effects
- If a rash occurs, guanfacine should be discontinued and the patient monitored appropriately 1
Guanfacine can be an effective option for ADHD treatment in children, particularly as a second-line agent or for those who cannot tolerate stimulants, but the side effect profile should be carefully considered when making treatment decisions.